{
  "directed": true,
  "graph": {
    "annotation_list": {
      "Custom_Disease": [
        "COVID-19"
      ],
      "PublicationStatus": [
        "Preprint",
        "Published"
      ],
      "PublicationType": [
        "Research",
        "Review"
      ],
      "Section": [
        "Abstract",
        "Full Text",
        "Results"
      ]
    },
    "annotation_pattern": {},
    "annotation_url": {
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20190128.belanno",
      "Species": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/species-taxonomy-id/species-taxonomy-id-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Shounak Baksi",
      "contact": "shounak.baksi@causalitybiomodels.com",
      "copyright": "Copyright © 2020 Fraunhofer Institute SCAI, All rights reserved",
      "description": "COVID Knowledge Curation project",
      "licenses": "Private Ownership to Fraunhofer Institute SCAI",
      "name": "32186952.bel",
      "version": "2.0.0"
    },
    "namespace_pattern": {
      "FIXME": ".*",
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns",
      "COVID": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns",
      "DRUGBANK": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/drugbank/drugbank-20180906.belns",
      "GO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go/go-20180109.belns",
      "HGNC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20190130.belns",
      "MESH": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns",
      "TAX": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns"
    },
    "path": "32186952.bel",
    "pybel_version": "0.14.6"
  },
  "links": [
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "According to WHO guidelines, infected patients will receive supportive care including oxygen therapy, fluid therapy, and antibiotics for treating secondary bacterial infections.",
      "key": "5269ed3238298481fc714699f845afad",
      "line": 84,
      "relation": "decreases",
      "source": 16,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "According to WHO guidelines, infected patients will receive supportive care including oxygen therapy, fluid therapy, and antibiotics for treating secondary bacterial infections.",
      "key": "dccbd7642f83aebd52235c2e6b16e4e3",
      "line": 86,
      "relation": "association",
      "source": 30,
      "target": 32
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "Furthermore, RNA synthesis inhibitors (like 3TC, TDF), remdesivir, neuraminidase inhibitors, peptide (EK1), anti-inflammatory drugs, abidol, Chinese traditional medicine, such as Lianhuaqingwen and ShuFengJieDu Capsules, could be the promising COVID-19 treatments.2",
      "key": "233341aa076095596cf61d333412c1d3",
      "line": 132,
      "relation": "positiveCorrelation",
      "source": 30,
      "target": 29
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "According to WHO guidelines, infected patients will receive supportive care including oxygen therapy, fluid therapy, and antibiotics for treating secondary bacterial infections.",
      "key": "be826bea0f8c15352acbe7df0b0bd226",
      "line": 85,
      "relation": "decreases",
      "source": 15,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "According to WHO guidelines, infected patients will receive supportive care including oxygen therapy, fluid therapy, and antibiotics for treating secondary bacterial infections.",
      "key": "f44dbf46735a9ed083ca9650e8060e83",
      "line": 86,
      "relation": "association",
      "source": 32,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "According to WHO guidelines, infected patients will receive supportive care including oxygen therapy, fluid therapy, and antibiotics for treating secondary bacterial infections.",
      "key": "d8d7476b1ce0eb5d6623ce645ba8c0f4",
      "line": 87,
      "relation": "decreases",
      "source": 14,
      "target": 32
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "The WHO also recommends the isolation of patients suspected or confirmed for COVID-19.16",
      "key": "940503c919e0eb1dbd274a812867bfd2",
      "line": 91,
      "relation": "decreases",
      "source": 33,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "The major therapeutic drugs that might be effective in managing COVID-19 include remdesivir, lopinavir/ritonavir alone or in combination with interferon-β, convalescent plasma, and mAbs.17 ",
      "key": "fd46b8862256906d288be9f61817c239",
      "line": 95,
      "relation": "decreases",
      "source": 10,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "Combination therapy with mAbs and the drug remdesivir could be an ideal therapeutic option for COVID-19",
      "key": "cf804b60bac7bf9dcea13f60097d2203",
      "line": 119,
      "relation": "decreases",
      "source": 10,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "The major therapeutic drugs that might be effective in managing COVID-19 include remdesivir, lopinavir/ritonavir alone or in combination with interferon-β, convalescent plasma, and mAbs.17 ",
      "key": "cac98cee829d937862fba11a242798b5",
      "line": 97,
      "relation": "decreases",
      "source": 2,
      "target": 30
    },
    {
      "key": "28398e61a65fc5dd2d2d19b5f0c1bdfc",
      "relation": "partOf",
      "source": 2,
      "target": 23
    },
    {
      "key": "f18924ce25341d06b4bb377528fcb9a5",
      "relation": "partOf",
      "source": 2,
      "target": 22
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "The major therapeutic drugs that might be effective in managing COVID-19 include remdesivir, lopinavir/ritonavir alone or in combination with interferon-β, convalescent plasma, and mAbs.17 ",
      "key": "33de7bdb16dfc69983d741e6efea8e06",
      "line": 98,
      "relation": "decreases",
      "source": 3,
      "target": 30
    },
    {
      "key": "b5ebd3ca4c04cc8bef8141da2f35053f",
      "relation": "partOf",
      "source": 3,
      "target": 23
    },
    {
      "key": "6a69b9c011b905760ffd20c4fc045a23",
      "relation": "partOf",
      "source": 3,
      "target": 22
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "The major therapeutic drugs that might be effective in managing COVID-19 include remdesivir, lopinavir/ritonavir alone or in combination with interferon-β, convalescent plasma, and mAbs.17 ",
      "key": "9b698160c07326b393cc732e300a27ab",
      "line": 99,
      "relation": "decreases",
      "source": 23,
      "target": 30
    },
    {
      "key": "72c03576b4c0ea78918dcfd822967397",
      "relation": "partOf",
      "source": 28,
      "target": 23
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "MeSHDisease": {
          "Convalescence": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "The major therapeutic drugs that might be effective in managing COVID-19 include remdesivir, lopinavir/ritonavir alone or in combination with interferon-β, convalescent plasma, and mAbs.17 ",
      "key": "164979efe5fd59b475d5c2753da7bf2e",
      "line": 101,
      "relation": "decreases",
      "source": 22,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "The S1 subunit has an RBD that interacts with its host cell receptor, angiotensin-converting enzyme 2 (ACE2), whereas the S2 subunit mediates fusion between the virus and host cell membranes for releasing viral RNA into the cytoplasm for replication.19 ",
      "key": "f9b14160a7be014f91c880c18879a5ae",
      "line": 106,
      "relation": "increases",
      "source": 25,
      "target": 20
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "The S1 subunit has an RBD that interacts with its host cell receptor, angiotensin-converting enzyme 2 (ACE2), whereas the S2 subunit mediates fusion between the virus and host cell membranes for releasing viral RNA into the cytoplasm for replication.19 ",
      "key": "58e727ee2bb796bdec45657508abdbf2",
      "line": 107,
      "relation": "increases",
      "source": 25,
      "target": 13
    },
    {
      "key": "2fac24f2b27106d2c0ea816941980bf5",
      "relation": "hasVariant",
      "source": 24,
      "target": 25
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "The S protein has a major role in the induction of protective immunity during infection with SARS-CoV by eliciting neutralizing-antibodies and T-cell responses.19 ",
      "key": "e87f6dedd576fc4cc63c58c7bc801f88",
      "line": 111,
      "relation": "increases",
      "source": 24,
      "target": 18
    },
    {
      "key": "14665e6cce9e8cd7bba8b188cdaad5f8",
      "relation": "partOf",
      "source": 4,
      "target": 20
    },
    {
      "key": "c71dbb188f7b0e5a7c8932ac254f5a1a",
      "relation": "partOf",
      "source": 4,
      "target": 19
    },
    {
      "key": "cff99abf5c2e57ced404ca1f88a8cb43",
      "relation": "partOf",
      "source": 27,
      "target": 20
    },
    {
      "key": "52cb6d8fcf894bbfe8497cecebc5b0d1",
      "relation": "partOf",
      "source": 27,
      "target": 21
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "The interactions between these epitopes and their corresponding MHC class I molecules were studied further by using molecular dynamics simulations and found that the CTL epitopes bind with MHC class I peptide-binding grooves via multiple contacts, thus indicating their potential for generating immune responses.30 ",
      "key": "03c6ffb324f2d2426341908440efd099",
      "line": 115,
      "relation": "increases",
      "source": 19,
      "target": 18
    },
    {
      "key": "3dbd9a23ad20ffb99d942da0608495bd",
      "relation": "partOf",
      "source": 26,
      "target": 19
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "The binding of COVID-19 and ACE2 affects the balance of renin–angiotensin system (RAS), potentially leading to exacerbation of severe pneumonia. Thus, it is speculated that ACEI and angiotensin type-1 receptor (AT1R) inhibitors might be able to reduce pulmonary inflammatory responses, thereby reducing the mortality.72",
      "key": "9e6655010847b52bf13fc880440e093e",
      "line": 123,
      "relation": "regulates",
      "source": 21,
      "target": 17
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "The binding of COVID-19 and ACE2 affects the balance of renin–angiotensin system (RAS), potentially leading to exacerbation of severe pneumonia. Thus, it is speculated that ACEI and angiotensin type-1 receptor (AT1R) inhibitors might be able to reduce pulmonary inflammatory responses, thereby reducing the mortality.72",
      "key": "3488e9f30f37f466454de7a9ae496fe2",
      "line": 124,
      "relation": "increases",
      "source": 21,
      "target": 31
    },
    {
      "key": "9b5e6ebdb508b622c266b4b986bd47ee",
      "relation": "partOf",
      "source": 12,
      "target": 21
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "Furthermore, RNA synthesis inhibitors (like 3TC, TDF), remdesivir, neuraminidase inhibitors, peptide (EK1), anti-inflammatory drugs, abidol, Chinese traditional medicine, such as Lianhuaqingwen and ShuFengJieDu Capsules, could be the promising COVID-19 treatments.2",
      "key": "c2165f54338f28b2fe5fdd4bb3891a38",
      "line": 128,
      "relation": "decreases",
      "source": 1,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "Furthermore, RNA synthesis inhibitors (like 3TC, TDF), remdesivir, neuraminidase inhibitors, peptide (EK1), anti-inflammatory drugs, abidol, Chinese traditional medicine, such as Lianhuaqingwen and ShuFengJieDu Capsules, could be the promising COVID-19 treatments.2",
      "key": "a1f36f2c47964f47e1b15a946274f45a",
      "line": 129,
      "relation": "decreases",
      "source": 11,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "Furthermore, RNA synthesis inhibitors (like 3TC, TDF), remdesivir, neuraminidase inhibitors, peptide (EK1), anti-inflammatory drugs, abidol, Chinese traditional medicine, such as Lianhuaqingwen and ShuFengJieDu Capsules, could be the promising COVID-19 treatments.2",
      "key": "df6c410c1868cdffdfeff0a3766fbd28",
      "line": 132,
      "relation": "positiveCorrelation",
      "source": 29,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "Furthermore, RNA synthesis inhibitors (like 3TC, TDF), remdesivir, neuraminidase inhibitors, peptide (EK1), anti-inflammatory drugs, abidol, Chinese traditional medicine, such as Lianhuaqingwen and ShuFengJieDu Capsules, could be the promising COVID-19 treatments.2",
      "key": "cb735cae1c0acc27b380812da0a2b10a",
      "line": 133,
      "relation": "decreases",
      "source": 6,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "Furthermore, RNA synthesis inhibitors (like 3TC, TDF), remdesivir, neuraminidase inhibitors, peptide (EK1), anti-inflammatory drugs, abidol, Chinese traditional medicine, such as Lianhuaqingwen and ShuFengJieDu Capsules, could be the promising COVID-19 treatments.2",
      "key": "cac64a5e191cbe02a6268d05628b4b16",
      "line": 134,
      "relation": "decreases",
      "source": 5,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "Furthermore, RNA synthesis inhibitors (like 3TC, TDF), remdesivir, neuraminidase inhibitors, peptide (EK1), anti-inflammatory drugs, abidol, Chinese traditional medicine, such as Lianhuaqingwen and ShuFengJieDu Capsules, could be the promising COVID-19 treatments.2",
      "key": "4720800d6e13c2727a22c52587070a88",
      "line": 135,
      "relation": "decreases",
      "source": 8,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "Furthermore, RNA synthesis inhibitors (like 3TC, TDF), remdesivir, neuraminidase inhibitors, peptide (EK1), anti-inflammatory drugs, abidol, Chinese traditional medicine, such as Lianhuaqingwen and ShuFengJieDu Capsules, could be the promising COVID-19 treatments.2",
      "key": "ca7e7ad32acea38d23c89bd312c8d0c5",
      "line": 136,
      "relation": "decreases",
      "source": 9,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "Furthermore, RNA synthesis inhibitors (like 3TC, TDF), remdesivir, neuraminidase inhibitors, peptide (EK1), anti-inflammatory drugs, abidol, Chinese traditional medicine, such as Lianhuaqingwen and ShuFengJieDu Capsules, could be the promising COVID-19 treatments.2",
      "key": "3fce6660f91dffc6b3bb33fab1e89d71",
      "line": 137,
      "relation": "decreases",
      "source": 7,
      "target": 30
    },
    {
      "annotations": {
        "Custom_Disease": {
          "COVID-19": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Review": true
        },
        "Section": {
          "Full Text": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Chaicumpa W",
          "Dadar M",
          "Dhama K",
          "Malik YS",
          "Sharun K",
          "Singh KP",
          "Tiwari R"
        ],
        "date": "2020-03-18",
        "db": "PubMed",
        "db_id": "32186952",
        "db_name": "Human vaccines &amp; immunotherapeutics",
        "first": "Dhama K",
        "last": "Chaicumpa W",
        "pages": "1-7"
      },
      "evidence": "Recently, the in vitro antiviral efficacy of approved drugs such as ribavirin, penciclovir, nitazoxanide, nafamostat, and chloroquine was compared with that of the two broad-spectrum antiviral drugs remdesivir and favipiravir for COVID-19. Among the evaluated drugs, both remdesivir and chloroquine were found to be highly effective in controlling COVID-19 in vitro.63 ",
      "key": "0819e0d910842531e877f56fbb4004b5",
      "line": 141,
      "relation": "decreases",
      "source": 0,
      "target": 30
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:chloroquine)",
      "concept": {
        "name": "chloroquine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "c368fe204031ce23a04cc402914492f6"
    },
    {
      "bel": "a(CHEBI:lamivudine)",
      "concept": {
        "name": "lamivudine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "eb5f5e5b9cc517467bd8ca915d9e17e4"
    },
    {
      "bel": "a(CHEBI:lopinavir)",
      "concept": {
        "name": "lopinavir",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "540f0a29f78ff437222f25e1c2e1b0fd"
    },
    {
      "bel": "a(CHEBI:ritonavir)",
      "concept": {
        "name": "ritonavir",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "07c1651afef7019b0cb107f1ce5fef12"
    },
    {
      "bel": "a(COVID:S)",
      "concept": {
        "name": "S",
        "namespace": "COVID"
      },
      "function": "Abundance",
      "id": "1cd7910c5ab81f81c9a15621a913c0bd"
    },
    {
      "bel": "a(DRUGBANK:DB13609)",
      "concept": {
        "name": "DB13609",
        "namespace": "DRUGBANK"
      },
      "function": "Abundance",
      "id": "e104a416a00a5773963f2e23ac09cb92"
    },
    {
      "bel": "a(FIXME:\"peptide EK1\")",
      "concept": {
        "name": "peptide EK1",
        "namespace": "FIXME"
      },
      "function": "Abundance",
      "id": "2935ad72de89b37cdc62fa11ad0ade3d"
    },
    {
      "bel": "a(FIXME:ShuFengJieDu)",
      "concept": {
        "name": "ShuFengJieDu",
        "namespace": "FIXME"
      },
      "function": "Abundance",
      "id": "1e62a15100de1bf2a23d7d3cc0620d32"
    },
    {
      "bel": "a(MESH:\"Medicine, Chinese Traditional\")",
      "concept": {
        "name": "Medicine, Chinese Traditional",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "b74a1ebaacfeac828bf9a3a0ec89b5de"
    },
    {
      "bel": "a(MESH:lianhuaqingwen)",
      "concept": {
        "name": "lianhuaqingwen",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "70d9e52f7f09c3ab92533dcb103ff895"
    },
    {
      "bel": "a(PUBCHEM:121304016)",
      "concept": {
        "name": "121304016",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "7704f9ea62204912dace9e0cfb704c95"
    },
    {
      "bel": "a(PUBCHEM:64987)",
      "concept": {
        "name": "64987",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "9697fb63e19113e7dd60c1e627fd72ba"
    },
    {
      "bel": "a(TAX:\"Severe acute respiratory syndrome coronavirus 2\")",
      "concept": {
        "name": "Severe acute respiratory syndrome coronavirus 2",
        "namespace": "TAX"
      },
      "function": "Abundance",
      "id": "c41851da59cc36c21b2e8acf24c1f46d"
    },
    {
      "bel": "bp(GO:\"intracellular transport of virus\")",
      "concept": {
        "name": "intracellular transport of virus",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "624c4306cfc1dc32a26861deb0776151"
    },
    {
      "bel": "bp(GO:\"response to antibiotic\")",
      "concept": {
        "name": "response to antibiotic",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "51e6f72ad73b47a927cb1941037385c4"
    },
    {
      "bel": "bp(MESH:\"Fluid Therapy\")",
      "concept": {
        "name": "Fluid Therapy",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "d3561230ae56efc66dceba883384d8a6"
    },
    {
      "bel": "bp(MESH:\"Oxygen Inhalation Therapy\")",
      "concept": {
        "name": "Oxygen Inhalation Therapy",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "385500825a3d4b39ec1414366a099975"
    },
    {
      "bel": "bp(MESH:\"Renin-Angiotensin System\")",
      "concept": {
        "name": "Renin-Angiotensin System",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "f80fbf58ffc396be8b673c9ad4850284"
    },
    {
      "bel": "bp(MESH:Immunity)",
      "concept": {
        "name": "Immunity",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "9e0bf623f2590a960b619d224ef1381a"
    },
    {
      "bel": "complex(a(COVID:S), p(GO:\"MHC class I protein complex\"))",
      "function": "Complex",
      "id": "3506a5268cd9fe938f2f816b002b5af5",
      "members": [
        {
          "bel": "a(COVID:S)",
          "concept": {
            "name": "S",
            "namespace": "COVID"
          },
          "function": "Abundance",
          "id": "1cd7910c5ab81f81c9a15621a913c0bd"
        },
        {
          "bel": "p(GO:\"MHC class I protein complex\")",
          "concept": {
            "name": "MHC class I protein complex",
            "namespace": "GO"
          },
          "function": "Protein",
          "id": "b2a73521660f4439b0a8c45ba5eb4dc3"
        }
      ]
    },
    {
      "bel": "complex(a(COVID:S), p(HGNC:ACE2))",
      "function": "Complex",
      "id": "0f4ebebda46021e4bab29748331ab187",
      "members": [
        {
          "bel": "a(COVID:S)",
          "concept": {
            "name": "S",
            "namespace": "COVID"
          },
          "function": "Abundance",
          "id": "1cd7910c5ab81f81c9a15621a913c0bd"
        },
        {
          "bel": "p(HGNC:ACE2)",
          "concept": {
            "name": "ACE2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "bb9a231a2c68ff8f3bad2adad9ed6a94"
        }
      ]
    },
    {
      "bel": "complex(a(TAX:\"Severe acute respiratory syndrome coronavirus 2\"), p(HGNC:ACE2))",
      "function": "Complex",
      "id": "146428e3b0f07633969567cac441971e",
      "members": [
        {
          "bel": "a(TAX:\"Severe acute respiratory syndrome coronavirus 2\")",
          "concept": {
            "name": "Severe acute respiratory syndrome coronavirus 2",
            "namespace": "TAX"
          },
          "function": "Abundance",
          "id": "c41851da59cc36c21b2e8acf24c1f46d"
        },
        {
          "bel": "p(HGNC:ACE2)",
          "concept": {
            "name": "ACE2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "bb9a231a2c68ff8f3bad2adad9ed6a94"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:lopinavir), a(CHEBI:ritonavir))",
      "function": "Composite",
      "id": "604986238aca313adcc37629dfa6e61a",
      "members": [
        {
          "bel": "a(CHEBI:lopinavir)",
          "concept": {
            "name": "lopinavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "540f0a29f78ff437222f25e1c2e1b0fd"
        },
        {
          "bel": "a(CHEBI:ritonavir)",
          "concept": {
            "name": "ritonavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "07c1651afef7019b0cb107f1ce5fef12"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:lopinavir), a(CHEBI:ritonavir), p(HGNC:IFNB1))",
      "function": "Composite",
      "id": "10ee6b4f9c3df1fea4db3315ff716b54",
      "members": [
        {
          "bel": "a(CHEBI:lopinavir)",
          "concept": {
            "name": "lopinavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "540f0a29f78ff437222f25e1c2e1b0fd"
        },
        {
          "bel": "a(CHEBI:ritonavir)",
          "concept": {
            "name": "ritonavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "07c1651afef7019b0cb107f1ce5fef12"
        },
        {
          "bel": "p(HGNC:IFNB1)",
          "concept": {
            "name": "IFNB1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "187da957c4e0c092e01fc85dd9da5fa4"
        }
      ]
    },
    {
      "bel": "p(COVID:S)",
      "concept": {
        "name": "S",
        "namespace": "COVID"
      },
      "function": "Protein",
      "id": "8d090715298e11996081058536798c19"
    },
    {
      "bel": "p(COVID:S, frag(\"?\"))",
      "concept": {
        "name": "S",
        "namespace": "COVID"
      },
      "function": "Protein",
      "id": "a4ea879b1d193de79d75f4ce77b539a5",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(GO:\"MHC class I protein complex\")",
      "concept": {
        "name": "MHC class I protein complex",
        "namespace": "GO"
      },
      "function": "Protein",
      "id": "b2a73521660f4439b0a8c45ba5eb4dc3"
    },
    {
      "bel": "p(HGNC:ACE2)",
      "concept": {
        "name": "ACE2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bb9a231a2c68ff8f3bad2adad9ed6a94"
    },
    {
      "bel": "p(HGNC:IFNB1)",
      "concept": {
        "name": "IFNB1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "187da957c4e0c092e01fc85dd9da5fa4"
    },
    {
      "bel": "p(HGNC:NEU1)",
      "concept": {
        "name": "NEU1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5dde1ecb95d48f27b5a899e1bec813d7"
    },
    {
      "bel": "path(DO:\"COVID-19\")",
      "concept": {
        "name": "COVID-19",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "6f9f1c2e8012537e503a758c6bfaff0f"
    },
    {
      "bel": "path(DO:pneumonia)",
      "concept": {
        "name": "pneumonia",
        "namespace": "DO"
      },
      "function": "Pathology",
      "id": "274776fc664e9bfd9c191cca80623b0d"
    },
    {
      "bel": "path(MESH:\"Bacterial Infections\")",
      "concept": {
        "name": "Bacterial Infections",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "99f1b853c8cfad351f262aee74a3716a"
    },
    {
      "bel": "path(MESH:\"Social Isolation\")",
      "concept": {
        "name": "Social Isolation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "6996cbe11809781667ce8f4dba02974e"
    }
  ]
}